非酶性ABHD6与Akt-FoxO1轴相互作用,以调节选择性肝脏胰岛素抵抗
bioRxiv : the preprint server for biology
|February 23, 2026
概括
这项研究表明,ABHD6的非酶功能调节选择性肝脏胰岛素耐药性和与代谢功能障碍相关的脂肪性肝病 (MASLD). 针对这种非酶活性,为MASLD和肝纤维化提供了一个新的治疗策略.
科学领域:
- 肝病学和代谢研究.
- 肝病的分子机制 肝病的分子机制
- 酶的功能和调节.
背景情况:
- 含有α/β-基酶域的蛋白6 (ABHD6) 以其在胰岛素分泌中的酶作用而闻名.
- 对于ABHD6的非酶功能,特别是肝脏健康的非酶功能,目前尚不清楚.
- 随着肥胖和衰老,ABHD6水平增加,这表明它在代谢功能障碍中起作用.
研究的目的:
- 调查ABHD6在选择性肝脏胰岛素抵抗中的非酶作用.
- 确定ABHD6对代谢功能障碍相关的脂肪性肝病 (MASLD) 和肝纤维化的贡献.
- 阐明ABHD6影响肝脏代谢的分子机制.
主要方法:
- 产生肝脏特异性的ABHD6淘汰和过度表达的小鼠模型.
- 对肝脏胰岛素抵抗,MASLD和肝纤维化标志物的分析.
- 研究ABHD6的核转移和与Akt/FoxO1信号通路的相互作用.
- 功能性研究涉及肝细胞淘汰/过度表达和AAV介导的基因传递在小鼠.
主要成果:
- ABHD6被确定为选择性肝脏胰岛素抵抗的新型调节剂,并有助于MASLD和肝纤维化.
- 这些效应的原因是ABHD6的非酶功能,而不是它的酶活性.
- ABHD6转移到核中,与Akt/FoxO1轴相互作用以调节FoxO1活动.
- FoxO1对于通过ABHD6调节葡萄糖耐受性和肝脏葡萄糖生成至关重要.
结论:
- ABHD6具有前所未知的非酶功能,对调节肝脏胰岛素耐药性至关重要.
- 这种ABHD6的非酶活性在MASLD和肝纤维化病变发生过程中起着重要作用.
- 针对ABHD6的非酶功能,为MASLD和相关的肝病提供了潜在的治疗途径.
相关概念视频
Insulin: The Receptor and Signaling Pathways
3.8K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
3.8K
PI3K/mTOR/AKT Signaling Pathway
5.8K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.8K
Hormones Regulating Blood Glucose
7.3K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
7.3K
cAMP-dependent Protein Kinase Pathways
8.6K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.6K


